bioRxiv Science⌕ Search

Biology subjects

Bloom, D. C.

Publications and source records attributed to Bloom, D. C..

3 recordsLinked to original sources

AAV-Mediated Ribozyme Targeting of HSV-1 Latency-Associated Transcript RNAs Reveals Distinct Functions of the LAT Intron and Exon In Vivo

Herpes Simplex Virus 1 (HSV-1) establishes lifelong latency in sensory neurons of the trigeminal ganglia (TG), from which periodic reactivation causes recurrent disease. The latency-associated transcript (LAT) has been implicated in latency establishment, neuronal survival, and reactivation; however, most functional studies have relied on viral deletion mutants that alter genomic architecture and disrupt overlapping noncoding RNAs, making transcript-specific functions difficult to define. To investigate LAT RNA function independent of viral genome modification, we used recombinant adeno-associated virus (rAAV) vectors to deliver hammerhead ribozymes targeting either the LAT exon or the stable LAT intron in a rabbit model of HSV-1 infection. We found that knocking down the LAT intron prior to HSV-1 infection significantly increased acute disease morbidity and reduced latent viral genome loads in the TG, whereas depletion of the LAT 5' exon had no detectable effect on latency establishment. LAT intron targeting was also associated with reduced abundance of both the intron and exon LAT transcripts during latency. In contrast, post-establishment depletion of either the LAT exon or intron significantly reduced reactivation-associated virus shedding following induced reactivation. These findings provide direct evidence that LAT-derived RNAs contribute to multiple stages of the HSV-1 life cycle. Furthermore, the differential effects of LAT exon and intron depletion suggest that functions required for efficient latency establishment localize more closely to the LAT intron, whereas both LAT exon and intron transcripts contribute to efficient reactivation. More broadly, this study demonstrates the utility of transcript-targeting approaches for dissecting the functions of complex herpesvirus noncoding RNA loci.

microbiology↗

Multiple long-range cis interactions generate CTCF insulator-dependent viral chromatin domains in quiescent HSV-1 genomes

In cellular genomes, CTCF insulators impact transcription over small distances in a one-dimensional manner and over much longer distances in a three-dimensional manner by maintaining chromatin loops. We have previously shown that the latent HSV-1 genome contains CTCF insulators that function to regulate lytic transcription of adjacent genes in a one-dimensional manner. Here, we test the hypothesis that HSV-1 CTCF insulators nucleate chromatin loops to regulate the expression of distance separated gene regions through three-dimensional organization of viral genomes. We used 4C-seq methods to identify multiple long-range cis interactions in HSV-1 genomes that generate viral chromatin domains, including those nucleated by the viral CTCF insulator CTRL2. Deletion of the CTRL2 insulator disrupted these viral chromatin domains. Loop-nucleating interactions were quantitated with a novel approach (UMI-4C-seq) that utilizes unique molecular identifiers to label and count chromatin interactions associated with specific viewpoint primers. Cis-interaction peaks across four different viewpoints were quantified. Viral genomes lacking CTRL2 displayed more cis-interaction peaks and wider ranges of interaction lengths compared to wt virus, suggesting altered chromatin organization. Furthermore, differential looping analysis showed viral genomes lacking CTRL2 displayed a more transcriptionally permissive chromatin environment. Thus, the CTRL2 insulator functions as a critical regulator of long-range chromatin interactions and its deletion reshapes the viral chromatin landscape, leading to a more accessible and dynamic regulatory environment that may influence HSV-1 transcriptional programs and latency-associated chromatin states.

microbiology↗

Immunization by replication-competent controlled herpesvirus vectors

Replication-competent controlled virus vectors were derived from virulent HSV-1 wildtype strain 17syn+ by placing one or two replication-essential genes under the stringent control of a gene switch that is co-activated by heat and an antiprogestin. Upon activation of the gene switch, the vectors replicate in infected cells with an efficacy that approaches that of the wildtype virus from which they were derived. Essentially no replication occurs in the absence of activation. When administered to mice, localized application of a transient heat treatment in the presence of systemic antiprogestin results in efficient but limited virus replication at the site of administration. The immunogenicity of these viral vectors was tested in a mouse footpad lethal challenge model. Unactivated viral vectors - which may be regarded as equivalents of inactivated vaccines - induced detectable protection against lethality caused by wildtype virus challenge. Single activation of the viral vectors at the site of administration (rear footpads) greatly enhanced protective immune responses, and second immunization resulted in complete protection. Once activated vectors also induced far better neutralizing antibody and HSV-1-specific T cells responses than unactivated vectors. To find out whether the immunogenicity of a heterologous antigen was also enhanced in the context of efficient transient vector replication, a virus vector constitutively expressing an equine influenza virus hemagglutinin was constructed. Immunization of mice with this recombinant induced detectable antibody-mediated neutralization of equine influenza virus as well as a hemagglutinin-specific T cell response. Single activation of viral replication resulted in a several-fold enhancement of this immune response.\n\nIMPORTANCEWe hypothesized that vigorous replication of a pathogen may be critical for eliciting the most potent and balanced immune response against it. Hence, attenuation/inactivation (as in conventional vaccines) should be avoided. Instead, necessary safety should be provided by placing replication of the pathogen under stringent control and of activating time-limited replication of the pathogen strictly in an administration region in which pathology cannot develop. Immunization will then occur in the context of highly efficient pathogen replication and uncompromised safety. We found that localized activation in mice of efficient but limited replication of a replication-competent controlled herpesvirus vector resulted in a greatly enhanced immune response to the virus or an expressed heterologous antigen. This finding supports the above hypothesis as well as suggests that the vectors may be promising novel agents worth exploring for the prevention/mitigation of infectious diseases for which efficient vaccination is lacking, in particular in immunocompromised patients.

immunology↗